"10.1371_journal.pone.0042623","plos one","2012-08-10T00:00:00Z","Ina M Ott; Markus L Alter; Karoline von Websky; Axel Kretschmer; Oleg Tsuprykov; Yuliya Sharkovska; Katharina Krause-Relle; Jens Raila; Andrea Henze; Johannes-Peter Stasch; Berthold Hocher","Institute for Nutritional Science, University of Potsdam, Potsdam, Germany; Center for Cardiovascular Research, Charité Campus Mitte, Berlin, Germany; Department of Nephrology, Charité Campus Benjamin Franklin, Berlin, Germany; Bayer HealthCare AG, Wuppertal, Germany; Institute of Pharmacy, University of Halle-Wittenberg, Halle (Saale), Germany","Conceived and designed the experiments: BH JR KW IMO MLA. Performed the experiments: IMO MLA KW OT YS KK AH. Analyzed the data: IMO MLA BH. Contributed reagents/materials/analysis tools: KW AK OT YS KK JS AH. Wrote the paper: IMO MLA.","This study was supported by Bayer HealthCare AG, Wuppertal, Germany, who played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript. Dr. Stasch and Dr. Kretschmer are employees of Bayer HealthCare AG, Wuppertal, Germany (http://www.wuppertal.bayer.de/). Bayer HealthCare AG holds the patent of riociguat (patent number: PIXXD2 WO 2003/095451). This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. No further conflicts of interest.","2012","08","Ina M Ott","IMO",11,TRUE,5,7,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
